Entero Therapeutics, Inc
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Boca Raton, Florida, focused on developing targeted orally delivered therapies for gastrointestinal diseases. Its innovative product portfolio includes latiglutenase for celiac disease, capeserod for multiple GI indications, and adrulipase for managing exocrine pancreatic insufficiency.
The company's research and development efforts target a variety of digestive disorders, encompassing conditions such as celiac disease, gastroparesis, and inflammatory bowel diseases. Through its proprietary technologies, Entero Therapeutics aims to address significant unmet medical needs within the realm of gastrointestinal health.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.